Insys Sponsors Cancer Caregivers Education Program

PHOENIX, May 25, 2017 -- Insys Therapeutics, Inc. (“Insys” or “the Company”) today announced its sponsorship of the Arizona Myeloma Network’s (“AzMN”) Cancer Caregivers Education Program^© (“CCEP”). The AzMN, a 2016 Top-Rated Nonprofit by Great Nonprofits, delivers free cancer education to myeloma patients as well as to all cancer caregivers and their families. The CCEP is a series of events designed and offered to the public free of charge by the AzMN to provide caregivers of cancer patients and the cancer patients’ teams with practical knowledge, skills and strategies necessary for effectively caring for their loved ones as well as themselves.

At the CCEP event, scheduled for June 3^rd, Dr. Steven Wong, M.D., board certified medical oncologist and hematologist from the UCLA Division of Hematology/Oncology, will discuss breakthrough cancer pain (“BTCP”), a major issue for not only myeloma patients, but for all cancer patients.  BTCP can negatively affect the quality of life for cancer patients and survivors. Cancer survivor, Judge (retired) Randall Morrison, will also share his own personal cancer pain journey.

“As a Company dedicated to developing and providing innovative care solutions for patients, Insys is proud to sponsor this CCEP event.  Educating cancer patients and caregivers on the cancer pain journey and breakthrough cancer pain is an integral part of our mission.  We extend our gratitude to AzMN for its efforts to raise awareness and the opportunity to partner with them on this important educational initiative,” said Saeed Motahari, President and CEO of Insys. 

“For Myeloma Awareness Month this past March, Arizona Governor Doug Ducey issued a proclamation to promote awareness of this rare and often misdiagnosed cancer,” said Barbara Kavanagh, Founder of AzMN. “We host events like CCEP for this very purpose and are especially grateful to Insys for their ongoing support over the years and for helping us to better educate cancer patients on the cancer pain journey,” she continued. “Insys truly takes their role in community engagement for the benefit of cancer patients and their families seriously.”

With June 4^th recognized as National Cancer Survivors Day by the American Cancer Society, the CCEP plans to include other topics relevant to cancer patient caregivers, cancer patients and survivors alike. The CCEP is free to the public and provides a continental breakfast with leading cancer specialists and resources. More information about the event is below.

CCEP Event Details

When: Saturday, June 3, 2017, 8:30-11:30 a.m.
Location: Drury Inn, 1205 S. Price Rd., Chandler, AZ 85286
Register: www.azmn.info/care
For more information: Visit www.azmyelomanetwork.org or call AzMN at 602-466-6246 

About INSYS

Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve the quality of life of patients. Using proprietary sublingual spray technology and capabilities to develop pharmaceutical cannabinoids, Insys is developing a pipeline of products intending to address unmet medical needs and the clinical shortcomings of existing commercial products. Insys currently markets one product, SUBSYS® (fentanyl sublingual spray) but has received approval for the marketing of SYNDROS™ (dronabinol) oral solution, CII, a proprietary, orally administered liquid formulation of dronabinol. Insys is committed to developing medications for potentially treating addiction to opioids, opioid overdose, epilepsy, and other disease areas with high unmet need.

SUBSYS® and SYNDROS™ are trademarks of Insys Development Company, Inc., a subsidiary of Insys Therapeutics, Inc.

About Arizona Myeloma Network (AzMN)

AzMN was founded in June 2004 by Barbara B. Kavanagh. Its mission is to promote awareness, education and advocacy for improved treatment and quality of life for multiple myeloma patients, their families and caregivers. AzMN members are patients, families, health care professionals, volunteers and others concerned about myeloma. AzMN is a nonprofit charity (501)(c)(3) organization that conducts outreach events and educational programs for Arizona myeloma cancer patients, their families and caregivers, with special consideration for the underserved: African American, Asian/Pacific, Hispanic American and Native American.

NOTE: All trademarks and registered trademarks are the property of their respective owners.

Media Contact:
Kara Stancell
480-650-5572
[email protected]